R&D
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Industry News | R&D
Oxford Genetics & ERS Genomics Extend Agreement
Their pre-existing non-exclusive, license agreement now includes the use of CRISPR gene editing technology in the APAC region09.20.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Propanc, University of Jaén, Spain Enter Collaboration
For the provision of research services and scientific technical advice for the Company's POP1 drug discovery program09.19.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Dyadic, Sanofi in Research Collaboration
To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest09.18.18
-
cGMP Manufacture | Clinical Trial Materials | Industry News | Laboratory Testing | R&D
PMI BioPharma Launches Research and Mfg. Facilities
Establishes research and manufacturing operations at multiple sites in Nashville and Celina, TN09.13.18
-
Analytical Services | Bio News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology | Laboratory Testing | R&D
FloDesign, Cognate Announce Collaboration
To advance the development of life saving therapeutics by improving manufacturing efficiencies using FloDesign's ACP Platform09.12.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
Boehringer Announces Positive Phase III Results
Confirmed that Cyltezo is equivalent to Humira, with no clinically meaningful differences in efficacy or safety09.12.18
-
Bio News | Industry News | Promotions & Moves | R&D
Codiak BioSciences Appoints EVP
Dr. Robert M. Brenner will also serve as head of Research and Development at the company09.11.18
-
Bio News | Breaking News | Drug Development | Drug Discovery | Industry News | Promotions & Moves | R&D
Aileron Therapeutics Names President & CEO
Manuel Aivado, MD, PhD has over 20 years experience, and has served as Aileron’s SVP, CMO, and CSO since 201209.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D | Trials & Filings
Gilead, Galapagos Announce Positive Phase 2 Results
In the TORTUGA study of filgotinib, an investigational, selective JAK1 inhibitor for the treatment of ankylosing spondylitis09.06.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
IRBM, Merck Enter Discovery Collaboration
To evaluate the potential of peptide-based therapeutic candidates09.05.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
Key Biologics, BCA Partner for Cell Therapy
Agreement enables deeper support of joint research and product development for cell therapy and regenerative medicine09.05.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
MoD Contracts Plasticell for Pilot Program
To develop regenerative medicines for the treatment of injuries resulting from combat or terrorism09.04.18
-
Bio News | Drug Development | Drug Discovery | Industry News | R&D
Regen BioPharma Reports Molecule Screening Success
Identified novel chemical compounds that appear to inhibit NR2F6 and show potential for treating autoimmune diseases08.30.18
-
Bio News | Drug Development | Industry News | R&D
REGENXBIO to Develop New Product
RGX-181, for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease08.30.18
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Information Technology | R&D
Ultimovacs Acquires Immuneed's Immunotherapy Unit
The NOK 50.4mm deal includes a rename of the business unit to Ultimovacs AB08.30.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
CHDI Extends Evotec Collaboration
The collaboration was initiated in 2006, and now will extend to 202308.30.18
-
Bio News | Bioanalytical Services | Breaking News | Facilities | Fill/Finish | Formulation Development | Industry News | R&D
Ajinomoto Althea Launches New Facility
57,000 sq. ft. ADC and Fill/Finish site will have areas dedicated to bioconjugation, formulation, purification, QC, and moreVideos
-
Bio News | Drug Development | Drug Discovery | Facilities | Industry News | R&D
KBI Biopharma BVBA Launches Belgium Lab Operations
Labs are co-located with JSR Life Sciences’ Amsphere A3 European mfg. site & represent KBI’s first Europe service offerings08.29.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
CPRIT Awards Forbius Product Development Grant
$18.75M will support operations and Phase 2a development of AVID100, a highly potent anti-EGFR antibody-drug conjugate08.27.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Strategia, JS InnoPharm Partner for Development
The strategic partnership alliance aims to facilitate global drug development of multiple therapeutics08.27.18
